Health Care · Life Sciences Tools & Services

Waters Corporation WAT

$381.52-2.38 (-0.62%)delayed quote · as of 2026-07-29 16:40 UTC

Open WAT in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$37.5B

Previous close

$383.90

Volume

214K

52-week range

$275.05 – $414.15

Verdictconfidence 100% · high

Growth, Health and Momentum stand out; value flashes caution.

4 of 5 dimensions score well; value flashes caution.

Value251/4 checks

Growth753/4 checks

Quality672/3 checks

Health1003/3 checks

Momentum804/5 checks

Fair-value estimate $106.40 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 259% above it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

48.5

P/E FWD

23.1

EV/EBITDA TTM

37.7

PEG

1.08

Growth

Revenue 3y

+2.1%/yr

Revenue YoY

+7.0%

Expected EPS

+109.8%

Quality

ROE

25.1%

Quality checks

bank measures

Health

Equity/assets

50.5%

Solvency score

n/a for financials

Momentum

vs 50-day

+19.5%

vs 200-day

+13.4%

52-wk range

77%

FY 2025: revenue $3.2B · net income $642.6M · free cash flow $539.8M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 16:40 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading WAT’s filed statements…

Continue with WAT in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.